Precision Orthopaedics Pioneer Onkos Surgical Secures $35M in Funding

Onkos Surgical, a pioneering force in the realm of musculoskeletal oncology and complex orthopedic procedures, is thrilled to announce a substantial funding achievement of $35 million. This robust investment underscores the confidence investors have in Onkos Surgical’s innovative approach, which utilizes Precision Orthopaedics to empower surgeons with critical data tailored to meet unique patient needs. With this funding, Onkos aims to further enhance its groundbreaking technologies, including advanced virtual surgical planning, 3D modeling and printing, cutting-edge implant design, and streamlined workflow optimization. The funding will predominantly be directed towards expanding the reach of our personalized solutions, ultimately improving patient outcomes and experiences across the healthcare landscape. Currently, more than 350 of the leading academic medical institutions in the U.S. rely on Onkos Surgical’s expertise, and with this new capital, we look forward to solidifying our position as a leader in the field. As we enter this next phase of growth, our commitment remains steadfast: to continually innovate and deliver state-of-the-art solutions that equip surgeons with the tools they need to navigate complex clinical challenges effectively. We are excited about the future and the potential impact that this funding will enable us to achieve in transforming the lives of countless patients facing musculoskeletal cancer and orthopedic issues.